...
首页> 外文期刊>Surgical Endoscopy >Phase II clinical experience and long-term follow-up using the next-generation single-incision platform FMX314
【24h】

Phase II clinical experience and long-term follow-up using the next-generation single-incision platform FMX314

机译:使用下一代单切口平台FMX314的II期临床经验和长期随访

获取原文
获取原文并翻译 | 示例
           

摘要

Background Single-incision minimally invasive surgery has previously been associated with incisions 2.0-3.0 cm in length. We present a novel single-incision surgical platform compatible for insertion through a standard 15-mm trocar we previously described in six patients with short-term follow-up data. The objective of this phase II study was to evaluate the safety and feasibility of the platform in a larger collective and to evaluate 1-year follow-up data of the phase I trial.
机译:背景技术单切口微创手术以前与2.0-3.0cm长的切口有关。我们提出了一种新颖的单切口手术平台,该平台可通过我们先前在六名具有短期随访数据的患者中描述的标准15毫米套管针进行插入。这项II期研究的目的是在更大的集体中评估该平台的安全性和可行性,并评估I期试验的1年随访数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号